Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Gregory Forlenza

Concepts (235)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Insulin Infusion Systems
92
2026
477
17.290
Why?
Diabetes Mellitus, Type 1
115
2026
3890
12.400
Why?
Insulin
94
2026
2507
9.410
Why?
Blood Glucose Self-Monitoring
79
2026
699
9.130
Why?
Hypoglycemic Agents
89
2026
1387
9.080
Why?
Pancreas, Artificial
31
2025
97
8.840
Why?
Blood Glucose
104
2026
2327
8.570
Why?
Hypoglycemia
35
2026
477
5.700
Why?
Hyperglycemia
15
2023
375
3.120
Why?
Hematopoietic Stem Cell Transplantation
5
2022
675
1.990
Why?
Diabetes Mellitus
10
2025
1098
1.700
Why?
Islets of Langerhans Transplantation
5
2024
67
1.630
Why?
Monitoring, Ambulatory
5
2018
88
1.630
Why?
Child
66
2026
22633
1.470
Why?
Adolescent
67
2026
22428
1.440
Why?
Pancreatectomy
5
2024
285
1.370
Why?
Algorithms
18
2025
1837
1.370
Why?
Humans
147
2026
144759
1.320
Why?
Insulin-Secreting Cells
3
2023
388
1.260
Why?
Pancreatitis, Chronic
4
2024
63
1.170
Why?
Biomedical Technology
2
2019
49
1.110
Why?
Young Adult
39
2026
14105
1.090
Why?
Verapamil
2
2023
37
0.990
Why?
Patient Education as Topic
3
2021
780
0.960
Why?
Diabetes Mellitus, Type 2
8
2025
2583
0.950
Why?
Adult
56
2026
40449
0.920
Why?
Male
64
2026
72315
0.830
Why?
Technology
5
2023
95
0.790
Why?
Telemedicine
3
2022
945
0.770
Why?
Female
63
2026
78271
0.770
Why?
Calcium Channel Blockers
1
2023
165
0.740
Why?
Caregivers
3
2025
1049
0.700
Why?
Child, Preschool
19
2025
11787
0.680
Why?
Lymphoma
1
2023
232
0.670
Why?
Self-Management
2
2026
201
0.670
Why?
Glucose
9
2024
1047
0.650
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2023
293
0.600
Why?
Patient Dropouts
1
2020
65
0.600
Why?
Treatment Outcome
19
2026
11679
0.590
Why?
Patient Satisfaction
3
2024
704
0.570
Why?
Personal Satisfaction
1
2020
222
0.560
Why?
Diabetic Ketoacidosis
5
2024
210
0.540
Why?
Eczema
1
2018
66
0.530
Why?
Transplantation Conditioning
1
2019
186
0.530
Why?
Betacoronavirus
1
2020
286
0.510
Why?
Diabetic Retinopathy
2
2024
208
0.490
Why?
Diffusion of Innovation
1
2017
98
0.490
Why?
Machine Learning
2
2025
585
0.450
Why?
Endocrine Glands
1
2015
14
0.450
Why?
Insulin, Regular, Human
7
2023
47
0.450
Why?
Quality of Life
4
2024
3185
0.450
Why?
Transplantation, Autologous
4
2024
290
0.440
Why?
Retrospective Studies
13
2025
17066
0.440
Why?
Endocrine System Diseases
1
2015
35
0.440
Why?
Insulin Lispro
3
2024
42
0.440
Why?
Pneumonia, Viral
1
2020
384
0.440
Why?
Aged
21
2026
25913
0.440
Why?
Coronavirus Infections
1
2020
378
0.440
Why?
C-Peptide
3
2025
189
0.430
Why?
Artificial Intelligence
1
2019
365
0.420
Why?
Exercise
9
2025
2201
0.420
Why?
Fanconi Anemia
1
2013
11
0.410
Why?
United States
16
2026
15966
0.410
Why?
Dwarfism
1
2013
15
0.410
Why?
Cross-Over Studies
7
2026
601
0.400
Why?
Growth Hormone
1
2013
92
0.400
Why?
Awareness
2
2026
108
0.400
Why?
Skin
1
2018
755
0.390
Why?
Middle Aged
24
2026
35875
0.390
Why?
Blindness
1
2012
52
0.370
Why?
Suicide
1
2020
720
0.360
Why?
Sequence Analysis, DNA
1
2015
824
0.360
Why?
High-Throughput Nucleotide Sequencing
1
2015
549
0.350
Why?
Pandemics
1
2020
1694
0.340
Why?
Angiogenesis Inhibitors
1
2012
237
0.330
Why?
Biosensing Techniques
2
2025
139
0.330
Why?
Calibration
3
2020
151
0.330
Why?
Lingual Frenum
1
2010
2
0.320
Why?
Tongue Diseases
1
2010
9
0.320
Why?
Failure to Thrive
1
2010
28
0.320
Why?
Cardiovascular Diseases
1
2022
2168
0.320
Why?
Randomized Controlled Trials as Topic
1
2016
1720
0.310
Why?
Epidemics
1
2011
98
0.310
Why?
Vascular Endothelial Growth Factor A
1
2012
557
0.310
Why?
Medicaid
3
2022
461
0.300
Why?
Medicare
3
2025
886
0.300
Why?
Models, Biological
1
2016
1821
0.290
Why?
Double-Blind Method
4
2023
2029
0.290
Why?
Infant
6
2023
10034
0.280
Why?
Skiing
2
2019
49
0.270
Why?
Follow-Up Studies
5
2021
5408
0.260
Why?
Adolescent Nutritional Physiological Phenomena
2
2017
29
0.260
Why?
Inventions
2
2018
19
0.260
Why?
Prospective Studies
7
2025
7990
0.250
Why?
Insurance Coverage
2
2025
239
0.250
Why?
Endocrinology
2
2018
77
0.230
Why?
Feasibility Studies
6
2026
1095
0.230
Why?
Meals
4
2024
130
0.230
Why?
Insulin Aspart
2
2022
30
0.230
Why?
Outpatients
2
2021
442
0.230
Why?
Injections, Subcutaneous
3
2020
164
0.220
Why?
Overweight
2
2023
609
0.220
Why?
Risk Factors
5
2020
10779
0.220
Why?
Postoperative Complications
2
2015
2919
0.220
Why?
Body Height
2
2017
202
0.210
Why?
Mutation
1
2015
4089
0.200
Why?
Eligibility Determination
1
2022
68
0.190
Why?
Insulins
1
2023
38
0.190
Why?
Equipment Failure
3
2018
115
0.190
Why?
Patient Safety
1
2025
347
0.180
Why?
Pediatrics
2
2020
1114
0.170
Why?
Automobile Driving
1
2023
155
0.160
Why?
Infusion Pumps, Implantable
1
2020
26
0.160
Why?
Computer Systems
1
2020
56
0.160
Why?
Smartphone
2
2019
102
0.150
Why?
Europe
3
2025
412
0.150
Why?
Sports
2
2019
211
0.150
Why?
Product Surveillance, Postmarketing
1
2019
72
0.150
Why?
Fatal Outcome
1
2020
307
0.150
Why?
Reproducibility of Results
4
2024
3409
0.140
Why?
Prevalence
3
2023
2834
0.140
Why?
Clinical Alarms
1
2017
10
0.140
Why?
Software
2
2021
690
0.130
Why?
Night Terrors
1
2017
1
0.130
Why?
Insulinoma
1
2017
28
0.130
Why?
Device Approval
1
2017
19
0.130
Why?
Diet, Diabetic
1
2017
33
0.130
Why?
Voluntary Health Agencies
1
2016
6
0.130
Why?
Survival Analysis
1
2020
1382
0.130
Why?
Adrenal Hyperplasia, Congenital
1
2017
39
0.120
Why?
Program Evaluation
1
2021
948
0.120
Why?
Pancreaticoduodenectomy
1
2017
135
0.120
Why?
Obesity
3
2023
3077
0.120
Why?
United States Food and Drug Administration
1
2017
203
0.120
Why?
Statistics as Topic
1
2016
284
0.120
Why?
Abdominal Pain
1
2017
146
0.120
Why?
Hypophosphatasia
1
2015
5
0.110
Why?
Age Factors
3
2018
3333
0.110
Why?
Drug Overdose
1
2020
370
0.110
Why?
Automation
2
2025
102
0.110
Why?
Drug Delivery Systems
1
2018
380
0.110
Why?
Alkaline Phosphatase
1
2015
145
0.110
Why?
History, 21st Century
2
2025
219
0.110
Why?
Autografts
1
2014
55
0.110
Why?
Pilot Projects
2
2020
1886
0.100
Why?
Health Services Accessibility
1
2022
1098
0.100
Why?
History, 20th Century
2
2025
325
0.100
Why?
Choristoma
1
2013
21
0.100
Why?
Glucose Clamp Technique
1
2014
199
0.100
Why?
Primary Ovarian Insufficiency
1
2013
40
0.100
Why?
Infusions, Intravenous
1
2014
423
0.100
Why?
Postoperative Period
1
2014
354
0.100
Why?
Clinical Decision-Making
1
2016
359
0.100
Why?
Pituitary Gland
1
2013
148
0.100
Why?
Graft Survival
1
2015
526
0.100
Why?
Allografts
1
2013
150
0.100
Why?
Bionics
2
2022
14
0.090
Why?
Patient Compliance
1
2017
588
0.090
Why?
Clinical Protocols
1
2014
282
0.090
Why?
Surveys and Questionnaires
2
2024
6048
0.090
Why?
Graft Rejection
1
2015
540
0.090
Why?
Genetic Testing
1
2015
478
0.090
Why?
Quality Improvement
1
2021
1289
0.090
Why?
Adolescent Behavior
1
2017
501
0.090
Why?
Pituitary Neoplasms
1
2013
190
0.090
Why?
Adipose Tissue
1
2016
652
0.090
Why?
Body Mass Index
2
2017
2438
0.090
Why?
Prognosis
2
2020
4282
0.080
Why?
Age of Onset
1
2012
551
0.080
Why?
Longitudinal Studies
3
2024
2947
0.080
Why?
Biomedical Research
1
2016
710
0.080
Why?
Critical Illness
1
2016
891
0.080
Why?
Activities of Daily Living
3
2017
441
0.070
Why?
Global Health
1
2012
401
0.070
Why?
Pancreatic Neoplasms
1
2017
919
0.070
Why?
Consensus
2
2022
488
0.070
Why?
Biomarkers
1
2020
4271
0.070
Why?
Electronic Health Records
1
2016
1173
0.070
Why?
Guideline Adherence
1
2012
589
0.070
Why?
Case-Control Studies
1
2015
3604
0.070
Why?
Equipment Design
2
2019
530
0.070
Why?
Societies, Medical
2
2024
887
0.070
Why?
Hospitalization
3
2024
2433
0.060
Why?
Infant, Newborn
1
2019
6429
0.060
Why?
Cold Temperature
2
2019
209
0.060
Why?
Weight Gain
1
2010
556
0.060
Why?
Breast Feeding
1
2010
448
0.060
Why?
Disposable Equipment
1
2026
24
0.060
Why?
Incidence
1
2012
2879
0.060
Why?
Time Factors
3
2025
7173
0.060
Why?
Seasons
2
2019
556
0.060
Why?
Practice Guidelines as Topic
1
2012
1560
0.050
Why?
Risk
2
2017
911
0.050
Why?
Child Abuse
1
2010
551
0.050
Why?
Combined Modality Therapy
2
2017
1266
0.050
Why?
Mass Screening
1
2012
1347
0.050
Why?
Diet
1
2011
1273
0.050
Why?
Quality-Adjusted Life Years
1
2023
121
0.050
Why?
Bayes Theorem
1
2025
433
0.050
Why?
Insulin Resistance
1
2011
1241
0.050
Why?
Standard of Care
1
2023
80
0.050
Why?
Pregnancy
2
2025
7190
0.050
Why?
Aged, 80 and over
2
2026
8265
0.040
Why?
Reference Standards
1
2021
177
0.040
Why?
Cohort Studies
2
2025
5960
0.040
Why?
Intention to Treat Analysis
1
2020
80
0.040
Why?
Cost-Benefit Analysis
1
2023
634
0.040
Why?
Social Conditions
1
2019
13
0.040
Why?
Pancreas
1
2022
341
0.040
Why?
Inpatients
1
2024
545
0.040
Why?
Disease Management
1
2023
645
0.040
Why?
Equipment and Supplies
1
2018
35
0.040
Why?
Health Personnel
1
2025
748
0.040
Why?
International Cooperation
1
2018
198
0.030
Why?
Postprandial Period
1
2018
118
0.030
Why?
Virginia
1
2017
55
0.030
Why?
Snacks
1
2017
23
0.030
Why?
Colorado
2
2017
4564
0.030
Why?
Ohio
1
2017
145
0.030
Why?
Reference Values
1
2018
797
0.030
Why?
Mobile Applications
1
2020
196
0.030
Why?
Child Nutritional Physiological Phenomena
1
2017
106
0.030
Why?
Minnesota
1
2017
169
0.030
Why?
Accelerometry
1
2017
119
0.030
Why?
Single-Blind Method
1
2017
312
0.030
Why?
Hypertrophy
1
2016
127
0.030
Why?
Food Preferences
1
2017
126
0.030
Why?
Materials Testing
1
2017
354
0.030
Why?
Healthcare Disparities
1
2022
727
0.030
Why?
Child Behavior
1
2017
236
0.030
Why?
Pain Measurement
1
2017
552
0.030
Why?
Feeding Behavior
1
2018
684
0.020
Why?
Practice Patterns, Physicians'
1
2018
1356
0.020
Why?
Severity of Illness Index
1
2017
2925
0.020
Why?
Magnetic Resonance Imaging
1
2017
3863
0.010
Why?
Forlenza's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)